Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today reported financial results for the three ...

Results show that targeting the underlying cause of Dravet syndrome with zorevunersen may improve outcomes for people with this rare, devastating genetic neurodevelopmental disease– ...

A team of researchers led by Rice University bioengineer Omid Veiseh has been awarded $18.2 million in funding from the Advanced Research Projects Agency for Health (ARPA-H) to develop a ...

Emirates suspends all flights to and from Dubai until March 7 amid West Asia conflict. US-Israel Iran War Highlights: ...